标题
Investigational drugs in recent clinical trials for treatment-resistant depression
作者
关键词
-
出版物
Expert Review of Neurotherapeutics
Volume 17, Issue 6, Pages 593-609
出版商
Informa UK Limited
发表日期
2017-01-17
DOI
10.1080/14737175.2017.1283217
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Buprenorphine and the treatment of depression, anxiety, non-suicidal self-injury, and suicidality
- (2016) L. Sher ACTA PSYCHIATRICA SCANDINAVICA
- Further Investigation of Ketamine
- (2016) Robert Freedman AMERICAN JOURNAL OF PSYCHIATRY
- A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
- (2016) Jaskaran B. Singh et al. AMERICAN JOURNAL OF PSYCHIATRY
- Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial
- (2016) Maurizio Fava et al. AMERICAN JOURNAL OF PSYCHIATRY
- Is Off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications
- (2016) Melvyn W. Zhang et al. BMC Medical Ethics
- Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort
- (2016) Raymond W. Lam et al. BMC Psychiatry
- Associations of low grade inflammation and endothelial dysfunction with depression – The Maastricht Study
- (2016) Fleur E.P. van Dooren et al. BRAIN BEHAVIOR AND IMMUNITY
- The Development of Rapastinel (Formerly GLYX-13); A Rapid Acting and Long Lasting Antidepressant
- (2016) Joseph Moskal et al. Current Neuropharmacology
- Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder
- (2016) Brittany Jaso et al. Current Neuropharmacology
- KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE
- (2016) William V. Bobo et al. DEPRESSION AND ANXIETY
- Investigational drugs for treating agitation in persons with dementia
- (2016) Ricardo P. Garay et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Therapeutic improvements expected in the near future for schizophrenia and schizoaffective disorder: an appraisal of phase III clinical trials of schizophrenia-targeted therapies as found in US and EU clinical trial registries
- (2016) Ricardo P. Garay et al. EXPERT OPINION ON PHARMACOTHERAPY
- The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: A randomized controlled study
- (2016) Cheng-Ta Li et al. HUMAN BRAIN MAPPING
- Prescription of Long-Acting Opioids and Mortality in Patients With Chronic Noncancer Pain
- (2016) Wayne A. Ray et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and Safety of Adjunctive Cariprazine in Inadequate Responders to Antidepressants
- (2016) Suresh Durgam et al. JOURNAL OF CLINICAL PSYCHIATRY
- Assessing the Risk Factors for Difficult-to-Treat Depression and Treatment-Resistant Depression
- (2016) Bradley Gaynes JOURNAL OF CLINICAL PSYCHIATRY
- Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine
- (2016) Dawn F. Ionescu et al. JOURNAL OF CLINICAL PSYCHIATRY
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites
- (2016) Panos Zanos et al. NATURE
- The Clinical and Cost Effectiveness of Vortioxetine for the Treatment of a Major Depressive Episode in Patients With Failed Prior Antidepressant Therapy: A Critique of the Evidence
- (2016) James Lomas et al. PHARMACOECONOMICS
- Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders
- (2016) Linda Nguyen et al. PHARMACOLOGY & THERAPEUTICS
- Quelle définition pour la dépression résistante ?
- (2016) Jérôme Holtzmann et al. PRESSE MEDICALE
- La feuille de route des stratégies thérapeutiques de la dépression résistante
- (2016) Wissam El-Hage PRESSE MEDICALE
- Dépression résistante : les autres stratégies thérapeutiques
- (2016) Ghassen Saba et al. PRESSE MEDICALE
- Role of glutamate receptors and glial cells in the pathophysiology of treatment-resistant depression
- (2016) Yong-Ku Kim et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Letter to the Editor: R-ketamine: a rapid-onset and sustained antidepressant without risk of brain toxicity
- (2016) K. Hashimoto PSYCHOLOGICAL MEDICINE
- Mirtazapine added to selective serotonin reuptake inhibitors for treatment-resistant depression in primary care (MIR trial): study protocol for a randomised controlled trial
- (2016) Debbie Tallon et al. Trials
- Evaluating antidepressant treatment prior to adding second-line therapies among patients with treatment-resistant depression
- (2016) Amany K. Hassan et al. International Journal of Clinical Pharmacy
- Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Efficacy Results From a Randomized, Double-Blind, Placebo-Controlled Study
- (2015) George I. Papakostas et al. AMERICAN JOURNAL OF PSYCHIATRY
- Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression
- (2015) D. Jeffrey Newport et al. AMERICAN JOURNAL OF PSYCHIATRY
- The promise of ketamine for treatment-resistant depression: current evidence and future directions
- (2015) Kaitlin E. DeWilde et al. Annals of the New York Academy of Sciences
- Treatment-resistant Late-life Depression: Challenges and Perspectives
- (2015) Christian Knochel et al. Current Neuropharmacology
- Potential serotonergic agents for the treatment of schizophrenia
- (2015) Ricardo P. Garay et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The preclinical profile of brexpiprazole: what is its clinical relevance for the treatment of psychiatric disorders?
- (2015) Leslie Citrome et al. Expert Review of Neurotherapeutics
- Brexpiprazole for schizophrenia and as adjunct for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antipsychotic - what is the number needed to treat, number needed to harm and likelihood to be hel
- (2015) L. Citrome INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia
- (2015) Jeffrey L. Cummings et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Adjunctive Brexpiprazole 1 and 3 mg for Patients With Major Depressive Disorder Following Inadequate Response to Antidepressants
- (2015) Michael E. Thase et al. JOURNAL OF CLINICAL PSYCHIATRY
- Efficacy and Safety of Adjunctive Brexpiprazole 2 mg in Major Depressive Disorder
- (2015) Michael E. Thase et al. JOURNAL OF CLINICAL PSYCHIATRY
- Randomized Proof of Concept Trial of GLYX-13, an N-Methyl-D-Aspartate Receptor Glycine Site Partial Agonist, in Major Depressive Disorder Nonresponsive to a Previous Antidepressant Agent
- (2015) SHELDON PRESKORN et al. Journal of Psychiatric Practice
- Is ketamine ready to be used clinically for the treatment of depression?
- (2015) Colleen Loo MEDICAL JOURNAL OF AUSTRALIA
- Minocycline as an adjunct for treatment-resistant depressive symptoms: study protocol for a pilot randomised controlled trial
- (2015) Muhammad I. Husain et al. Trials
- Circulating interleukin-6 and cancer: A meta-analysis using Mendelian randomization
- (2015) Geng Tian et al. Scientific Reports
- The preclinical profile of brexpiprazole: what is its clinical relevance for the treatment of psychiatric disorders?
- (2015) Leslie Citrome et al. Expert Review of Neurotherapeutics
- Protocol and Rationale-The Efficacy of Minocycline as an Adjunctive Treatment for Major Depressive Disorder: A Double Blind, Randomised, Placebo Controlled Trial
- (2015) Olivia May Dean et al. Clinical Psychopharmacology and Neuroscience
- Sirukumab, a human anti-interleukin-6 monoclonal antibody: a randomised, 2-part (proof-of-concept and dose-finding), phase II study in patients with active rheumatoid arthritis despite methotrexate therapy
- (2014) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- NMDA antagonists under investigation for the treatment of major depressive disorder
- (2014) Bartłomiej Pochwat et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression
- (2014) J. Craig Nelson et al. JOURNAL OF AFFECTIVE DISORDERS
- C-reactive protein, interleukin-6, soluble tumor necrosis factor α receptor 2 and incident clinical depression
- (2014) Patricia O. Chocano-Bedoya et al. JOURNAL OF AFFECTIVE DISORDERS
- Safety, Tolerability, and Clinical Effect of Low-Dose Buprenorphine for Treatment-Resistant Depression in Midlife and Older Adults
- (2014) Jordan F. Karp et al. JOURNAL OF CLINICAL PSYCHIATRY
- Review of Maintenance Trials for Major Depressive Disorder
- (2014) Silvana Borges et al. JOURNAL OF CLINICAL PSYCHIATRY
- Efficacy and Safety of Olanzapine/Fluoxetine Combination vs Fluoxetine Monotherapy Following Successful Combination Therapy of Treatment-Resistant Major Depressive Disorder
- (2014) Elizabeth Brunner et al. NEUROPSYCHOPHARMACOLOGY
- Evaluation of Opioid Modulation in Major Depressive Disorder
- (2014) Elliot Ehrich et al. NEUROPSYCHOPHARMACOLOGY
- Involvement of Sigma-1 Receptors in the Antidepressant-like Effects of Dextromethorphan
- (2014) Linda Nguyen et al. PLoS One
- A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes
- (2014) A. McGirr et al. PSYCHOLOGICAL MEDICINE
- A Neurobiological Hypothesis of Treatment-Resistant Depression – Mechanisms for Selective Serotonin Reuptake Inhibitor Non-Efficacy
- (2014) Jeremy D. Coplan et al. Frontiers in Behavioral Neuroscience
- Association of Serum Interleukin 6 and C-Reactive Protein in Childhood With Depression and Psychosis in Young Adult Life
- (2014) Golam M. Khandaker et al. JAMA Psychiatry
- Effect of Anti-inflammatory Treatment on Depression, Depressive Symptoms, and Adverse Effects
- (2014) Ole Köhler et al. JAMA Psychiatry
- New paradigms for treatment-resistant depression
- (2013) Carlos Zarate et al. Annals of the New York Academy of Sciences
- Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
- (2013) Undine E. Lang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- CRP, IL-6 and depression: A systematic review and meta-analysis of longitudinal studies
- (2013) Vyara Valkanova et al. JOURNAL OF AFFECTIVE DISORDERS
- A review of ketamine in affective disorders: Current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action
- (2013) Marie Naughton et al. JOURNAL OF AFFECTIVE DISORDERS
- Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach
- (2013) Roger S. McIntyre et al. JOURNAL OF AFFECTIVE DISORDERS
- Effects of S-Ketamine as an Anesthetic Adjuvant to Propofol on Treatment Response to Electroconvulsive Therapy in Treatment-Resistant Depression
- (2013) Kaija Järventausta et al. JOURNAL OF ECT
- Daily Oral Ketamine for the Treatment of Depression and Anxiety in Patients Receiving Hospice Care: A 28-Day Open-Label Proof-of-Concept Trial
- (2013) Scott A. Irwin et al. JOURNAL OF PALLIATIVE MEDICINE
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
- (2013) Stefan Leucht et al. LANCET
- Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects
- (2013) G Sanacora et al. MOLECULAR PSYCHIATRY
- R (−)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine
- (2013) Ji-chun Zhang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- A Randomized Trial of a Low-Trapping Nonselective N-Methyl-D-Aspartate Channel Blocker in Major Depression
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
- (2012) James W. Murrough et al. BIOLOGICAL PSYCHIATRY
- Treatment-emergent adverse events associated with atypical antipsychotics
- (2012) Danielle S Cha et al. EXPERT OPINION ON PHARMACOTHERAPY
- A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder
- (2012) Lobna Ibrahim et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Minocycline as adjunctive therapy for patients with unipolar psychotic depression: An open-label study
- (2012) Tsuyoshi Miyaoka et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature
- (2012) A. J. Ferrari et al. PSYCHOLOGICAL MEDICINE
- Treatment-resistant depression: therapeutic trends, challenges, and future directions
- (2012) Al-harbi Patient Preference and Adherence
- Ketamine as a Novel Antidepressant: From Synapse to Behavior
- (2011) J W Murrough CLINICAL PHARMACOLOGY & THERAPEUTICS
- Drug safety evaluation of ziprasidone
- (2011) Leslie Citrome Expert Opinion On Drug Safety
- Treatment-Resistant Depression
- (2011) Michael E. Thase JOURNAL OF CLINICAL PSYCHIATRY
- Cariprazine (RGH-188), a potent D3/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in vivo and shows antipsychotic-like and procognitive effects in rodents
- (2011) István Gyertyán et al. NEUROCHEMISTRY INTERNATIONAL
- Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens
- (2011) Adam L. Halberstadt et al. NEUROPHARMACOLOGY
- Towards a glutamate hypothesis of depression
- (2011) Gerard Sanacora et al. NEUROPHARMACOLOGY
- Tocilizumab
- (2010) Adith Venkiteshwaran mAbs
- Adjunctive Aripiprazole, Olanzapine, or Quetiapine for Major Depressive Disorder: An Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed
- (2010) Leslie Citrome POSTGRADUATE MEDICINE
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
- (2010) N. Li et al. SCIENCE
- Stuck in a rut: rethinking depression and its treatment
- (2010) Paul E. Holtzheimer et al. TRENDS IN NEUROSCIENCES
- RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ)
- (2009) Gregory M. Chandler et al. CNS Neuroscience & Therapeutics
- σ-1 receptors in major depression and anxiety
- (2009) Shrinivas K Kulkarni et al. Expert Review of Neurotherapeutics
- Sequenced Treatment Alternatives to Relieve Depression (STAR*D)
- (2009) Robert H. Howland JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES
- Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder
- (2008) Richard C. Shelton et al. ACTA PSYCHIATRICA SCANDINAVICA
- Glutamate and the Neural Basis of the Subjective Effects of Ketamine
- (2008) J. F. William Deakin et al. ARCHIVES OF GENERAL PSYCHIATRY
- Psychosocial disability and work role function compared across the long-term course of bipolar I, bipolar II and unipolar major depressive disorders
- (2007) Lewis L. Judd et al. JOURNAL OF AFFECTIVE DISORDERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started